Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.45 - $0.86 $31,371 - $59,954
69,714 New
69,714 $36,000
Q1 2022

May 16, 2022

SELL
$0.75 - $1.77 $35,445 - $83,651
-47,261 Reduced 50.31%
46,687 $37,000
Q4 2021

Feb 14, 2022

BUY
$1.56 - $2.93 $7,132 - $13,395
4,572 Added 5.12%
93,948 $152,000
Q3 2021

Nov 15, 2021

BUY
$2.91 - $4.83 $69,129 - $114,741
23,756 Added 36.2%
89,376 $268,000
Q2 2021

Aug 16, 2021

BUY
$4.17 - $5.74 $107,018 - $147,311
25,664 Added 64.23%
65,620 $306,000
Q1 2021

May 17, 2021

BUY
$5.28 - $9.64 $18,115 - $33,074
3,431 Added 9.39%
39,956 $211,000
Q4 2020

Feb 16, 2021

BUY
$5.75 - $7.13 $23,793 - $29,503
4,138 Added 12.78%
36,525 $238,000
Q3 2020

Nov 16, 2020

BUY
$4.9 - $7.12 $98,450 - $143,055
20,092 Added 163.42%
32,387 $198,000
Q4 2019

Feb 14, 2020

SELL
$8.49 - $12.81 $2.71 Million - $4.09 Million
-319,457 Reduced 96.29%
12,295 $108,000
Q3 2019

Nov 14, 2019

SELL
$5.58 - $14.47 $1.27 Million - $3.29 Million
-227,285 Reduced 40.66%
331,752 $3.72 Million
Q2 2019

Aug 14, 2019

SELL
$5.22 - $9.08 $614,962 - $1.07 Million
-117,809 Reduced 17.41%
559,037 $3.39 Million
Q1 2019

May 15, 2019

BUY
$5.35 - $9.82 $2.91 Million - $5.34 Million
543,685 Added 408.29%
676,846 $0
Q4 2018

Feb 14, 2019

SELL
$3.43 - $6.19 $2.14 Million - $3.87 Million
-625,033 Reduced 82.44%
133,161 $660,000
Q3 2018

Nov 13, 2018

BUY
$4.75 - $14.5 $3.4 Million - $10.4 Million
715,686 Added 1683.65%
758,194 $0
Q2 2018

Aug 10, 2018

BUY
$13.3 - $17.45 $359,937 - $472,249
27,063 Added 175.22%
42,508 $0
Q1 2018

May 11, 2018

SELL
$14.7 - $24.95 $1.14 Million - $1.94 Million
-77,691 Reduced 83.42%
15,445 $248,000
Q4 2017

Feb 09, 2018

SELL
$19.9 - $29.25 $23.6 Million - $34.7 Million
-1,186,316 Reduced 92.72%
93,136 $2.16 Million
Q3 2017

Nov 09, 2017

BUY
$15.1 - $19.25 $19.3 Million - $24.6 Million
1,279,452
1,279,452 $23.6 Million

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.